Lawyers for AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson argued at a panel hearing in Philadelphia late last week ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

The biopharma industry is on an upward trajectory, driven by groundbreaking advances in treatment options and a rising demand ...

Bristol Myers Squibb exceeded third-quarter profit expectations with $3.7 billion earnings, due to strong sales in established and new drugs. Revenue climbed 8%, hitting $11.89 billion. However, the ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

My daughter’s annual pharmacy bill is routinely a multiple of my salary as a state employee whose family relies on the health ...

Pharmaceutical manufacturers urged the U.S. Court of ... for a "maximum fair price" for its blood clot prevention medicine Eliquis, to avoid paying $1 billion per day in fines or exiting Medicare ...

Targets the reduction in CABG-related bleeding severity due to the blood thinning drug, ticagrelor – a major unmet medical need in heart attack ...

So far, the Biden administration has set caps for the price of a number of drugs for Medicare patients, including Eliquis for blood clots, Entresto for heart failure and insulin. Those will take ...

A patient was discharged with a prescription for Eliquis but their insurance requires a prior authorization that will take three–four days to process? No problem, here’s a 30-day manufacturer coupon!” ...

The Health Canada Medical Device License (MDL) authorizes manufacturers to import or ... removal of the direct oral anticoagulants (DOAC) apixaban and rivaroxaban in a cardiopulmonary bypass ...